These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 20379729

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Assembly of tau in transgenic animals expressing P301L tau: alteration of phosphorylation and solubility.
    Sahara N, Lewis J, DeTure M, McGowan E, Dickson DW, Hutton M, Yen SH.
    J Neurochem; 2002 Dec; 83(6):1498-508. PubMed ID: 12472903
    [Abstract] [Full Text] [Related]

  • 4. Metabolic status of CSF distinguishes rats with tauopathy from controls.
    Karlíková R, Mičová K, Najdekr L, Gardlo A, Adam T, Majerová P, Friedecký D, Kováč A.
    Alzheimers Res Ther; 2017 Sep 21; 9(1):78. PubMed ID: 28934963
    [Abstract] [Full Text] [Related]

  • 5. Analysis of tau phosphorylation and truncation in a mouse model of human tauopathy.
    Delobel P, Lavenir I, Fraser G, Ingram E, Holzer M, Ghetti B, Spillantini MG, Crowther RA, Goedert M.
    Am J Pathol; 2008 Jan 21; 172(1):123-31. PubMed ID: 18079436
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Tau Fibril Formation in Cultured Cells Compatible with a Mouse Model of Tauopathy.
    Matsumoto G, Matsumoto K, Kimura T, Suhara T, Higuchi M, Sahara N, Mori N.
    Int J Mol Sci; 2018 May 17; 19(5):. PubMed ID: 29772786
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Methods for measuring tau pathology in transgenic mouse models.
    Forest SK, Acker CM, d'Abramo C, Davies P.
    J Alzheimers Dis; 2013 May 17; 33(2):463-71. PubMed ID: 22976073
    [Abstract] [Full Text] [Related]

  • 12. Cerebrospinal Fluid and Plasma Tau as a Biomarker for Brain Tauopathy.
    Shoji M.
    Adv Exp Med Biol; 2019 May 17; 1184():393-405. PubMed ID: 32096052
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Biochemical classification of tauopathies by immunoblot, protein sequence and mass spectrometric analyses of sarkosyl-insoluble and trypsin-resistant tau.
    Taniguchi-Watanabe S, Arai T, Kametani F, Nonaka T, Masuda-Suzukake M, Tarutani A, Murayama S, Saito Y, Arima K, Yoshida M, Akiyama H, Robinson A, Mann DMA, Iwatsubo T, Hasegawa M.
    Acta Neuropathol; 2016 Feb 17; 131(2):267-280. PubMed ID: 26538150
    [Abstract] [Full Text] [Related]

  • 15. Vaccination with Sarkosyl insoluble PHF-tau decrease neurofibrillary tangles formation in aged tau transgenic mouse model: a pilot study.
    Ando K, Kabova A, Stygelbout V, Leroy K, Heraud C, Frédérick C, Suain V, Yilmaz Z, Authelet M, Dedecker R, Potier MC, Duyckaerts C, Brion JP.
    J Alzheimers Dis; 2014 Feb 17; 40 Suppl 1():S135-45. PubMed ID: 24614899
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Tau reduction prevents neuronal loss and reverses pathological tau deposition and seeding in mice with tauopathy.
    DeVos SL, Miller RL, Schoch KM, Holmes BB, Kebodeaux CS, Wegener AJ, Chen G, Shen T, Tran H, Nichols B, Zanardi TA, Kordasiewicz HB, Swayze EE, Bennett CF, Diamond MI, Miller TM.
    Sci Transl Med; 2017 Jan 25; 9(374):. PubMed ID: 28123067
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.